Human Papillomavirus InfectionSymptoms, Doctors, Treatments, Advances & More
Human Papillomavirus Infection Overview
Learn About Human Papillomavirus Infection
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Dr. Carole Fakhry is a head and neck surgical oncologist at Johns Hopkins and treats the breadth of patients with head and neck cancers, including cancers of the tonsils, base of tongue, mouth, larynx, thyroid, salivary gland (parotid, submandibular gland) and skin cancers among others. She is the Chief of the Division of Head and Neck Surgery and Director of the Head and Neck Cancer Center. She also serves as director of the head and neck group in the Bloomberg~Kimmel Institute for Cancer Immunotherapy and the head and neck surgical oncology fellowship. She is the associate editor for Oral Oncology and serves on several editorial boards. After an undergraduate degree at Stanford University, she completed medical school, residency in otolaryngology head and neck surgery, and a fellowship in head and neck surgical oncology at Johns Hopkins. She has also received a master’s in public health from the Johns Hopkins Bloomberg School of Public Health. She is presently a professor in the Johns Hopkins Department of Otolaryngology-Head and Neck Surgery, Oncology, and Johns Hopkins Bloomberg School of Public Health Department of Epidemiology. Her research interest focuses on the role of human papillomavirus (HPV) in head and neck squamous cell cancer. She has demonstrated that the presence of HPV confers a prognostic advantage to individuals with oropharyngeal cancer and that HPV is associated with unique clinical characteristics. In addition to the clinical implications of HPV in head and neck cancer, she is co-principal investigator of a large study to understand screening individuals at “high risk” of malignancy and evaluating imaging modalities to improve diagnostics and early detection of HPV- related head and neck cancer. Dr. Fakhry is rated as an Elite provider by MediFind in the treatment of Human Papillomavirus Infection. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Human Papillomavirus Infection, Head and Neck Squamous Cell Carcinoma (HNSCC), Salivary Gland Tumors, Laryngectomy, and Gastrostomy. Dr. Fakhry is board certified in Head And Neck Surgery.
Cleveland Clinic Main Campus
Joseph Scharpf is an Otolaryngologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 32 years. Dr. Scharpf is rated as an Elite provider by MediFind in the treatment of Human Papillomavirus Infection. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Human Papillomavirus Infection, Thyroidectomy, and Laryngectomy. Dr. Scharpf is board certified in American Board Of Otolaryngology, 2005.
Cleveland Clinic Main Campus
Shlomo Koyfman is an Otolaryngologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 24 years. Dr. Koyfman is rated as an Elite provider by MediFind in the treatment of Human Papillomavirus Infection. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, Laryngectomy, and Thyroidectomy. Dr. Koyfman is board certified in American Board Of Radiology, 2012.
Summary: This study is being done to answer the following question: Are there types of early-stage vulvar cancer that require either less or more treatment than the usual approach?
Summary: The purpose of this study is to compare the efficacy and safety of ficlatuzumab plus cetuximab compared to placebo plus cetuximab in participants with recurrent/metastatic (R/M) HPV-negative Head and Neck Cancer. The primary hypothesis is that ficlatuzumab combined with cetuximab is superior to cetuximab alone in terms of progression-free survival and/or overall survival.

